Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | DHODH | Q02127 | 10/20 | 0.36 |
| ▸ | PPOX | P50336 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | BRAF | P15056 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7234497 | 0.93 | DHODH (0.38) | DHODHPPOXALDH1A1 | |
| SCHEMBL7227543 | 0.92 | PPOX (0.45) | KMT2AL3MBTL1DHODHPPOXSMN1; SMN2 | |
| SCHEMBL12981626 | 0.90 | PPOX (0.43) | DHODHPPOXSMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL7178022 | 0.90 | PPOX (0.43) | DHODHPPOXSMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL6644418 | 0.90 | ACACB (0.36) | MEN1MAPTKMT2AL3MBTL1DHODH | |
| SCHEMBL7227471 | 0.89 | POLB (0.36) | MEN1MAPTKMT2AL3MBTL1DHODH | |
| SCHEMBL3140584 | 0.89 | BCAT1 (0.38) | DHODHPPOX | |
| SCHEMBL6639012 | 0.88 | DHODH (0.34) | MEN1MAPTKMT2AL3MBTL1DHODH | |
| SCHEMBL6637980 | 0.86 | DHODH (0.39) | DHODH | |
| SCHEMBL7221822 | 0.86 | DHODH (0.37) | DHODHPPOXALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6667413-B2 | Aniline derivatives; herbicides; nonphytotoxic | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-12-23 | — | — | US | disclosed |
| US-20030130124-A1 | Herbicides | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-07-10 | — | — | US | disclosed |
| US-6451740-B2 | HERBICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-09-17 | — | — | US | disclosed |
| US-20020013466-A1 | Uracil compounds and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-01-31 | — | — | US | disclosed |
| EP-1106607-A2 | Uracil compounds and their use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130124-A1 | Herbicides | CBR3, CBR1, MT-CO1 | MEN1 3863/4885MAPT 4776/4885KMT2A 1323/4885 |
| US-20020013466-A1 | Uracil compounds and use thereof | UNG, MRM1, OGG1 | MEN1 2823/4885MAPT 4788/4885KMT2A 2006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.